Search results

As the count of new seed deals steadily shrinks, some founders are finding new funding paths.

Valuation step-up multiples trended up last year at Series A and Series B. Series C was a different story.

Last year’s figures in late-stage dealmaking were far off the late-stage market’s peak in 2021. They’re also still lagging behind the pre-pandemic funding market of 2019.

While volatility diminished in 2023, fundraising activity in the startup ecosystem remained near recent lows in Q4 2023.

Growth shares are a type of security for mature companies that have outgrown government share schemes. Learn how growth shares and growth share valuations work.

Median valuations soared at Series D and Series E+ in Q4 2023, a promising fundraising sign for late-stage startups.

The median primary Series A round size reached $11.3 million in Q4 and the median valuation hit $44.8 million, climbing for the third straight quarter.

Initial data from Q4 2023 suggests the year ended with a slight uptick in valuations across most venture capital stages.

The biotech seed market is booming, fintech is experiencing a slowdown, and other key sector takeaways from 2023.

Learn what the process looks like for private companies, what auditors look for, and how to best prepare.

A 409A valuation should be strategic—not perfunctory. Carta can help companies of all sizes get a fast, accurate, and data-backed valuation in a matter of days.